T-SPOT.TB responses during treatment of pulmonary tuberculosis. - Wikidata - wikimedia - TriplyDB

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

http://www.wikidata.org/entity/Q33413454

about

Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.The performance and limitation of T-SPOT.TB for the diagnosis of TB in a high prevalence setting Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar.Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts.Recombinant ESAT-6-CFP10 Fusion Protein Induction of Th1/Th2 Cytokines and FoxP3 Expressing Treg Cells in Pulmonary TB Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery Diagnostic value of T-SPOT.TB interferon-γ release assays for active tuberculosis.Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting.Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.Diagnostic Significance of Mycobacterium tuberculosis T-cell Assays for Active Tuberculosis.Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment.Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.Differential Recognition of Mycobacterium tuberculosis-Specific Epitopes as a Function of Tuberculosis Disease History.Comparison of Interferon-γ Release Assays and the Tuberculin Skin Test for Diagnosis of Tuberculosis in Human Immunodeficiency Virus: A Systematic Review.

P2860

Q28475371-171C3574-2334-4A5F-89CC-0D8AE885ED4D Q28729742-2B8B5E3C-C3A1-44C5-B0CB-08CC75589BB4 Q30979334-7D3F5DD1-1C1B-4A8E-B6CA-F2E7247D68A2 Q33638976-B09EE261-7428-4E11-8DAC-E90BC9AB99CE Q33814812-4B957174-A571-4F60-A829-2C29ADD38B5C Q33909191-89309F26-7586-42D0-BE3F-B124174BD29D Q33962683-47E36D6F-1E4A-40D1-A67D-BC9E85253B11 Q34412119-9BE2531F-F82D-4B07-873F-5D3A7D6AFE73 Q34512206-650612FA-626C-44F5-A213-2F38DCF745C2 Q34797776-83440C31-4484-4EBF-B2CA-19172441BB62 Q35063982-8FB1F257-D2F3-4292-8217-274C4AC6502B Q35138740-BEB6558D-0466-42DD-B9AD-D7DD013594BD Q35361654-4FAE8793-6DDD-4B2F-A230-5166B17A644E Q35802723-9D315B90-FD51-4A8A-946B-423D659904F6 Q36516077-31C4BE4C-8477-4228-A52F-9C6232B3C744 Q36637982-076C73BD-7185-49BF-9199-7DA42FB7416B Q37544916-9EC0CEAB-FC5C-4995-9BC0-CE093BEB18B3 Q37615219-8F95B5E2-023D-4BF1-891F-0FD011270BBA Q37649784-779DB9EB-B680-4F8E-912F-944213994814 Q37738306-75F53E05-E12E-404D-A004-D9EC8E18315A Q39036474-458E831D-3DCE-487D-8CC2-6EF904D8DA12 Q39604583-2F1A5A13-99E1-4DA8-A96A-690B9B4B1404 Q40101402-2FAAF4B9-F870-442A-9DC9-8763859DB1AE Q47284740-3BBD0813-BD38-447A-9DD7-4D7A1E1F3D6F

P2860

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

http://www.wikidata.org/entity/Q33413454

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

@ast

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

@en

type

label

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

@ast

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

@en

prefLabel

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

@ast

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

@en

P1433

Q33413454-F731E1EE-5146-49C5-9E06-FB74A3F4DF4B

P1476

Q33413454-B16F5476-338A-4EF8-A0BF-0238E71CA3CF

P2093

Q33413454-40950744-8A5A-4DFB-8415-34AA50AE9BE4

Q33413454-41052ECD-0B65-43FB-A709-4792BABD7C59

Q33413454-48DEB8D1-6D28-4B8A-8801-C0EDF732BB56

Q33413454-72D11CA8-1951-412A-8AF7-C4D32353026F

Q33413454-8F967D1C-2D6A-4C18-B0E5-294DACF8EC58

Q33413454-C7BB495A-BA65-4450-85F5-299CEE02EE44

Q33413454-EAC55895-FE0E-4BF2-AF77-18A662777DEA

Q33413454-ED62787D-9B3C-479C-B503-BDA6B9B0E695

P2860

Q33413454-0BAB9939-9DA4-4B03-BB39-80841E136369

Q33413454-19AC87A6-5447-40ED-8710-388416BA475F

Q33413454-6E95C92D-FD88-43AA-9A89-ABB01CECED7C

Q33413454-73ACD8F5-3B65-478C-BAE1-1AEDD4CD1C0B

Q33413454-74921A45-1C79-49FF-A016-7D145BCB3340

Q33413454-76CB4A69-2FF1-4B19-BF76-AD9DE0405952

Q33413454-7E939DB5-A277-465D-B113-3C981747C8D4

Q33413454-7ECD6A30-B088-4023-9066-2F32FDB6F9F3

Q33413454-820AC2FC-B004-4F27-B19C-1723C42E044A

Q33413454-8376A70E-C77C-4738-94A4-63526A5D4B89

P2888

Q33413454-B744A969-5312-4739-9090-A9F325F65A96

P304

Q33413454-531EF28F-D2A9-4915-A973-6F06847A6834

P31

Q33413454-AF011256-7FC3-40CC-BBC0-5B9566424ED9

P356

Q33413454-89910831-7FE1-49B8-A82A-A88F68757885

P478

Q33413454-E36F4444-D6EF-4354-826A-C4857EF2F927

P50

Q33413454-831657A0-1545-4475-AA97-228C4ED56652

P577

Q33413454-909BE777-B733-4627-9267-F74914D78062

P5875

Q33413454-F542A0EF-4F81-4DF9-ACCA-D2537CB1BC8B

P6179

Q33413454-D79B34DB-5B57-404C-BB67-830D2688C7A4

P698

Q33413454-251B0DB9-2966-48DB-AF12-89FFB1CD6F82

P921

Q33413454-9796B607-5667-43AD-A225-2A9BB2DF349A

P932

Q33413454-D29E82FF-3E0B-4317-B703-89DA6A807C34

P356

P1433

BMC Infectious Diseases

P1476

T-SPOT.TB responses during treatment of pulmonary tuberculosis.

@en

P2093

Anne Efron

http://www.w3.org/2001/XMLSchema#string

Carla Loredo

http://www.w3.org/2001/XMLSchema#string

Judith Hackman

http://www.w3.org/2001/XMLSchema#string

Kelly Dooley

http://www.w3.org/2001/XMLSchema#string

Marcus B Conde

http://www.w3.org/2001/XMLSchema#string

Neio Boechat

http://www.w3.org/2001/XMLSchema#string

Samantha Ribeiro

http://www.w3.org/2001/XMLSchema#string

Susan E Dorman

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice

Longitudinal data analysis for discrete and continuous outcomes

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases.

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.

Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma.

Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment.

T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure.

Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study.

P2888

P304

23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-9-23

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Richard E Chaisson

P577

2009-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24145144

http://www.w3.org/2001/XMLSchema#string

P6179

1049703701

http://www.w3.org/2001/XMLSchema#string

P698

19250549

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

2651889

http://www.w3.org/2001/XMLSchema#string